Kapplingattu S, Bhattacharya S, Adlakha Y
Cell Death Discov. 2025; 11(1):7.
PMID: 39805813
PMC: 11729916.
DOI: 10.1038/s41420-024-02283-x.
Son G, Na Y, Kim Y, Son J, Clemenson G, Schafer S
Commun Biol. 2024; 7(1):1393.
PMID: 39455851
PMC: 11511827.
DOI: 10.1038/s42003-024-07089-2.
Nateghi B, Keraudren R, Boulay G, Bazin M, Goupil C, Canet G
Front Neurosci. 2024; 18:1421680.
PMID: 39170678
PMC: 11337869.
DOI: 10.3389/fnins.2024.1421680.
Hossain M, Tareq M, Biswas P, Tauhida S, Bibi S, Zilani M
J Cell Mol Med. 2024; 28(16):e18588.
PMID: 39153206
PMC: 11330274.
DOI: 10.1111/jcmm.18588.
Azam H, Rossling R, Geithe C, Khan M, Dinter F, Hanack K
Front Mol Neurosci. 2024; 17:1386735.
PMID: 38883980
PMC: 11177777.
DOI: 10.3389/fnmol.2024.1386735.
Tumor Suppressor MicroRNAs in Clinical and Preclinical Trials for Neurological Disorders.
Lui A, Do T, Alzayat O, Yu N, Phyu S, Santuya H
Pharmaceuticals (Basel). 2024; 17(4).
PMID: 38675388
PMC: 11054060.
DOI: 10.3390/ph17040426.
Posttranscriptional regulation of by miR-124-3p at rs3512 underlies onset-delaying genetic modification in Huntington's disease.
Kim K, Hong E, Lee Y, McLean Z, Elezi E, Lee R
Proc Natl Acad Sci U S A. 2024; 121(16):e2322924121.
PMID: 38607933
PMC: 11032436.
DOI: 10.1073/pnas.2322924121.
A Comprehensive Bioinformatics Approach to Identify Molecular Signatures and Key Pathways for the Huntington Disease.
Meem T, Khan U, Mredul M, Awal M, Rahman M, Khan M
Bioinform Biol Insights. 2023; 17:11779322231210098.
PMID: 38033382
PMC: 10683407.
DOI: 10.1177/11779322231210098.
Brain-Derived Neurotrophic Factor Dysregulation as an Essential Pathological Feature in Huntington's Disease: Mechanisms and Potential Therapeutics.
Speidell A, Bin Abid N, Yano H
Biomedicines. 2023; 11(8).
PMID: 37626771
PMC: 10452871.
DOI: 10.3390/biomedicines11082275.
Regulation of rat HspB5/alphaB-Crystallin by microRNAs miR-101a-3p, miR-140-5p, miR-330-5p, and miR-376b-3p.
Bartelt-Kirbach B, Golenhofen N
Cell Stress Chaperones. 2023; 28(6):787-799.
PMID: 37584866
PMC: 10746672.
DOI: 10.1007/s12192-023-01371-8.
Dysregulated miRNA and mRNA Expression Affect Overlapping Pathways in a Huntington's Disease Model.
Zsindely N, Nagy G, Siagi F, Farkas A, Bodai L
Int J Mol Sci. 2023; 24(15).
PMID: 37569316
PMC: 10419151.
DOI: 10.3390/ijms241511942.
Repressor Element-1 Binding Transcription Factor (REST) as a Possible Epigenetic Regulator of Neurodegeneration and MicroRNA-Based Therapeutic Strategies.
Nassar A, Satarker S, Gurram P, Upadhya D, Fayaz S, Nampoothiri M
Mol Neurobiol. 2023; 60(10):5557-5577.
PMID: 37326903
PMC: 10471693.
DOI: 10.1007/s12035-023-03437-1.
Peripheral Biomarkers in Manifest and Premanifest Huntington's Disease.
Morena E, Romano C, Marconi M, Diamant S, Buscarinu M, Bellucci G
Int J Mol Sci. 2023; 24(7).
PMID: 37047023
PMC: 10094222.
DOI: 10.3390/ijms24076051.
Regulation of LncRNAs and microRNAs in neuronal development and disease.
Xuan C, Yang E, Zhao S, Xu J, Li P, Zhang Y
PeerJ. 2023; 11:e15197.
PMID: 37038472
PMC: 10082570.
DOI: 10.7717/peerj.15197.
miR-34a-5p as molecular hub of pathomechanisms in Huntington's disease.
Hart M, Diener C, Lunkes L, Rheinheimer S, Krammes L, Keller A
Mol Med. 2023; 29(1):43.
PMID: 37013480
PMC: 10295337.
DOI: 10.1186/s10020-023-00640-7.
MicroRNA‑124: an emerging therapeutic target in central nervous system disorders.
Zhang W, Jiang L, Li M, Liu J
Exp Brain Res. 2023; 241(5):1215-1226.
PMID: 36961552
PMC: 10129929.
DOI: 10.1007/s00221-022-06524-2.
Recent Advances in the Roles of MicroRNA and MicroRNA-Based Diagnosis in Neurodegenerative Diseases.
Zhang J, Chen Z, Chen H, Deng Y, Li S, Jin L
Biosensors (Basel). 2022; 12(12).
PMID: 36551041
PMC: 9776063.
DOI: 10.3390/bios12121074.
Dual role of brain-derived extracellular vesicles in dementia-related neurodegenerative disorders: cargo of disease spreading signals and diagnostic-therapeutic molecules.
Natale F, Fusco S, Grassi C
Transl Neurodegener. 2022; 11(1):50.
PMID: 36437458
PMC: 9701396.
DOI: 10.1186/s40035-022-00326-w.
Gene Alterations Induced by Glutamine (Q) Encoding CAG Repeats Associated with Neurodegeneration.
Saha G, Ghosh S, Dubey V, Saudagar P
Methods Mol Biol. 2022; 2575:3-23.
PMID: 36301468
DOI: 10.1007/978-1-0716-2716-7_1.
MicroRNA binding site variation is enriched in psychiatric disorders.
Geaghan M, Reay W, Cairns M
Hum Mutat. 2022; 43(12):2153-2169.
PMID: 36217923
PMC: 10947041.
DOI: 10.1002/humu.24481.